top of page

Welcome to the SCOOTT Trial

Icon of a hand waving

The SCOOTT trial investigates how best to treat basal thumb osteoarthritis once a patient has been referred to secondary care. ​

​

The animation below provides further information on why we are running the trial and patient activities involved in participation.  

​

​

Summary of the Trial

  • Base of thumb osteoarthritis affects 1 in 5 people over the age of 40, causing thumb pain, tenderness and stiffness which negatively impacts activities of daily living and quality of life.

  • There are several treatments available for base of thumb osteoarthritis, each with different advantages and disadvantages but we do not yet have strong evidence about which is best overall. 

  • The SCOOTT trial is looking to recruit 656 adults with symptomatic base of thumb osteoarthritis presenting to surgeons at 20 NHS hospitals across the United Kingdom

  • Participants will be randomly allocated to receive either trapeziectomy (removing the trapezium, a bone at the base of the thumb), CMCJR (carpometacarpal joint replacement) or enhanced non-surgical management (The ENGAGE Package)

  • Participants will complete 7 questionnaires over a period of 18-months following entry into the trial. 

  • A summary of trial findings will be available for participants and be communicated to them, unless participants do not want to receive this. 

​

 

SCOOTT Patient Infographic V1.0 17.07.2024 - JPG.jpg

To find out more about becoming a patient on the trial, please read the Participant Information Sheet: Participant Information Sheet 

 

SCOOTT Trial

 

              York Trials Unit, Department of Health Sciences, ARRC Building, Area 4, University of York,                        Heslington, York, YO10 5DD

​

              ytu-scoott-trial@york.ac.uk

​

NIHR Number: NIHR154694 - IRAS ID: 336574

​

 Disclaimer - Privacy - Accessibility - University Privacy Notice - University Legal Statements

                              

This project was funded by the NIHR Health Technology Assessment Programme (Reference: NIHR154694). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

bottom of page